UK SMEs Can Help Restock The AMR Toolbox, But Only If The ‘Broken Market’ Is Fixed
Executive Summary
The UK must build greater capacity and offer funding to support small but “highly innovative” biotechs, which are instrumental in developing solutions to combat antimicrobial resistance, the chief executive of Scotland’s NovaBiotics argues.